Immunogenic, cellular, and angiogenic drivers of tumor dormancy-a melanoma view
Published 2015 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Immunogenic, cellular, and angiogenic drivers of tumor dormancy-a melanoma view
Authors
Keywords
-
Journal
Pigment Cell & Melanoma Research
Volume 29, Issue 1, Pages 27-42
Publisher
Wiley
Online
2015-10-30
DOI
10.1111/pcmr.12432
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- mTORC1 Activation Blocks BrafV600E-Induced Growth Arrest but Is Insufficient for Melanoma Formation
- (2015) William Damsky et al. CANCER CELL
- Intravital Imaging Reveals How BRAF Inhibition Generates Drug-Tolerant Microenvironments with High Integrin β1/FAK Signaling
- (2015) Eishu Hirata et al. CANCER CELL
- Fibronectin induction abrogates the BRAF inhibitor response of BRAF V600E/PTEN-null melanoma cells
- (2015) I V Fedorenko et al. ONCOGENE
- UPR, autophagy, and mitochondria crosstalk underlies the ER stress response
- (2015) Daniela Senft et al. TRENDS IN BIOCHEMICAL SCIENCES
- Intact LKB1 activity is required for survival of dormant ovarian cancer spheroids
- (2015) Teresa Peart et al. Oncotarget
- HIGD1A Regulates Oxygen Consumption, ROS Production, and AMPK Activity during Glucose Deprivation to Modulate Cell Survival and Tumor Growth
- (2015) Kurosh Ameri et al. Cell Reports
- Thrombospondin 1 promotes an aggressive phenotype through epithelial-to-mesenchymal transition in human melanoma
- (2015) Aparna Jayachandran et al. Oncotarget
- Axl as a mediator of cellular growth and survival
- (2015) Haley Axelrod et al. Oncotarget
- GAS6/AXL Axis Regulates Prostate Cancer Invasion, Proliferation, and Survival in the Bone Marrow Niche
- (2015) Yusuke Shiozawa et al. NEOPLASIA
- TBK1 Regulates Prostate Cancer Dormancy through mTOR Inhibition
- (2015) Jin Koo Kim et al. NEOPLASIA
- Immunosurveillance by Antiangiogenesis: Tumor Growth Arrest by T Cell–Derived Thrombospondin-1
- (2014) Keri L. Schadler et al. CANCER RESEARCH
- Identification of a ZEB2-MITF-ZEB1 transcriptional network that controls melanogenesis and melanoma progression
- (2014) G Denecker et al. CELL DEATH AND DIFFERENTIATION
- Oncogenic BRAF induces chronic ER stress condition resulting in increased basal autophagy and apoptotic resistance of cutaneous melanoma
- (2014) M Corazzari et al. CELL DEATH AND DIFFERENTIATION
- New insights into cancer immunoediting and its three component phases—elimination, equilibrium and escape
- (2014) Deepak Mittal et al. CURRENT OPINION IN IMMUNOLOGY
- PI3K signalling is required for a TGFβ-induced epithelial-mesenchymal-like transition (EMT-like) in human melanoma cells
- (2014) Natalie C. Schlegel et al. EXPERIMENTAL DERMATOLOGY
- IL-2: The First Effective Immunotherapy for Human Cancer
- (2014) S. A. Rosenberg JOURNAL OF IMMUNOLOGY
- TGF- : Duality of Function Between Tumor Prevention and Carcinogenesis
- (2014) D. R. Principe et al. JNCI-Journal of the National Cancer Institute
- Adjuvant bevacizumab in patients with melanoma at high risk of recurrence (AVAST-M): preplanned interim results from a multicentre, open-label, randomised controlled phase 3 study
- (2014) Pippa G Corrie et al. LANCET ONCOLOGY
- Setting the bar for adjuvant treatment of melanoma
- (2014) Vernon K Sondak et al. LANCET ONCOLOGY
- Direct measurement of local oxygen concentration in the bone marrow of live animals
- (2014) Joel A. Spencer et al. NATURE
- Tissue mechanics modulate microRNA-dependent PTEN expression to regulate malignant progression
- (2014) Janna K Mouw et al. NATURE MEDICINE
- Tumor heterogeneity and plasticity as elusive drivers for resistance to MAPK pathway inhibition in melanoma
- (2014) A Roesch ONCOGENE
- Thrombospondin-1 is part of a Slug-independent motility and metastatic program in cutaneous melanoma, in association with VEGFR-1 and FGF-2
- (2014) Patrizia Borsotti et al. Pigment Cell & Melanoma Research
- Vascular channels formed by subpopulations of PECAM1+ melanoma cells
- (2014) James M. Dunleavey et al. Nature Communications
- Low MITF/AXL ratio predicts early resistance to multiple targeted drugs in melanoma
- (2014) Judith Müller et al. Nature Communications
- A Melanoma Cell State Distinction Influences Sensitivity to MAPK Pathway Inhibitors
- (2014) D. J. Konieczkowski et al. Cancer Discovery
- Type I Cytokines Synergize with Oncogene Inhibition to Induce Tumor Growth Arrest
- (2014) N. Acquavella et al. Cancer Immunology Research
- Bevacizumab plus Ipilimumab in Patients with Metastatic Melanoma
- (2014) F. S. Hodi et al. Cancer Immunology Research
- Response to BRAF Inhibition in Melanoma Is Enhanced When Combined with Immune Checkpoint Blockade
- (2014) Z. A. Cooper et al. Cancer Immunology Research
- Evidence of synergy with combined BRAF-targeted therapy and immune checkpoint blockade for metastatic melanoma
- (2014) Zachary A Cooper et al. OncoImmunology
- The Impact of the Immune System on Tumor: Angiogenesis and Vascular Remodeling
- (2014) Christian Stockmann et al. Frontiers in Oncology
- Crosstalk of Oncogenic Signaling Pathways during Epithelial–Mesenchymal Transition
- (2014) Stephan Lindsey et al. Frontiers in Oncology
- Insights into the Transforming Growth Factor-β Signaling Pathway in Cutaneous Melanoma
- (2013) Carole Yolande Perrot et al. Annals of Dermatology
- The pre-metastatic niche: finding common ground
- (2013) Jaclyn Sceneay et al. CANCER AND METASTASIS REVIEWS
- Directed Phenotype Switching as an Effective Antimelanoma Strategy
- (2013) Magalí Sáez-Ayala et al. CANCER CELL
- A Switch in the Expression of Embryonic EMT-Inducers Drives the Development of Malignant Melanoma
- (2013) Julie Caramel et al. CANCER CELL
- The Dormancy Dilemma: Quiescence versus Balanced Proliferation
- (2013) Alan Wells et al. CANCER RESEARCH
- LOX-Mediated Collagen Crosslinking Is Responsible for Fibrosis-Enhanced Metastasis
- (2013) T. R. Cox et al. CANCER RESEARCH
- Mechanisms Governing Metastatic Dormancy and Reactivation
- (2013) Filippo G. Giancotti CELL
- Type III TGF-β receptor downregulation generates an immunotolerant tumor microenvironment
- (2013) Brent A. Hanks et al. JOURNAL OF CLINICAL INVESTIGATION
- Severe adverse events from the treatment of advanced melanoma: a systematic review of severe side effects associated with ipilimumab, vemurafenib, interferon alfa-2b, dacarbazine and interleukin-2
- (2013) Chelsea Ma et al. JOURNAL OF DERMATOLOGICAL TREATMENT
- Hypoxia Contributes to Melanoma Heterogeneity by Triggering HIF1α-Dependent Phenotype Switching
- (2013) Daniel S. Widmer et al. JOURNAL OF INVESTIGATIVE DERMATOLOGY
- Oncogenic Activation of MEK/ERK Primes Melanoma Cells for Adaptation to Endoplasmic Reticulum Stress
- (2013) Amanda Croft et al. JOURNAL OF INVESTIGATIVE DERMATOLOGY
- Late Recurrence in Melanoma: Clinical Implications of Lost Dormancy
- (2013) Mark B. Faries et al. JOURNAL OF THE AMERICAN COLLEGE OF SURGEONS
- T-helper-1-cell cytokines drive cancer into senescence
- (2013) Heidi Braumüller et al. NATURE
- TGF-β2 dictates disseminated tumour cell fate in target organs through TGF-β-RIII and p38α/β signalling
- (2013) Paloma Bragado et al. NATURE CELL BIOLOGY
- The perivascular niche regulates breast tumour dormancy
- (2013) Cyrus M. Ghajar et al. NATURE CELL BIOLOGY
- A chemical biology approach identifies AMPK as a modulator of melanoma oncogene MITF
- (2013) V Borgdorff et al. ONCOGENE
- Couldpericytic mimicryrepresent another type of melanoma cell plasticity with embryonic properties?
- (2013) Claire Lugassy et al. Pigment Cell & Melanoma Research
- GAS6 Receptor Status Is Associated with Dormancy and Bone Metastatic Tumor Formation
- (2013) Russell S. Taichman et al. PLoS One
- Up-Regulation of PD-L1, IDO, and Tregs in the Melanoma Tumor Microenvironment Is Driven by CD8+ T Cells
- (2013) S. Spranger et al. Science Translational Medicine
- The PI3K/AKT Signaling Pathway Controls the Quiescence of the Low-Rhodamine123-Retention Cell Compartment Enriched for Melanoma Stem Cell Activity
- (2013) Yasmine Touil et al. STEM CELLS
- Hypoxia Induces Phenotypic Plasticity and Therapy Resistance in Melanoma via the Tyrosine Kinase Receptors ROR1 and ROR2
- (2013) M. P. O'Connell et al. Cancer Discovery
- The prostate cancer bone marrow niche: more than just ‘fertile soil’
- (2012) Elisabeth A Pedersen et al. ASIAN JOURNAL OF ANDROLOGY
- LKB1/STK11 Inactivation Leads to Expansion of a Prometastatic Tumor Subpopulation in Melanoma
- (2012) Wenjin Liu et al. CANCER CELL
- The BMP Inhibitor Coco Reactivates Breast Cancer Cells at Lung Metastatic Sites
- (2012) Hua Gao et al. CELL
- PHF19 and Akt control the switch between proliferative and invasive states in melanoma
- (2012) Stephanie Ghislin et al. CELL CYCLE
- Staying alive
- (2012) James R. Valcourt et al. CELL CYCLE
- The Role of Angiogenesis Inhibitors in the Management of Melanoma
- (2012) Kamarul Ahmad Zaki et al. CURRENT TOPICS IN MEDICINAL CHEMISTRY
- Local expression of interleukin-2 by B16 melanoma cells results in decreased tumour growth and long-term tumour dormancy
- (2012) Scott A. Gerber et al. IMMUNOLOGY
- Hypoxia Stabilizes GAS6/Axl Signaling in Metastatic Prostate Cancer
- (2012) Anjali Mishra et al. MOLECULAR CANCER RESEARCH
- Melanomas resist T-cell therapy through inflammation-induced reversible dedifferentiation
- (2012) Jennifer Landsberg et al. NATURE
- Combination of MEK and SRC inhibition suppresses melanoma cell growth and invasion
- (2012) J Ferguson et al. ONCOGENE
- The receptor tyrosine kinase Axl is an essential regulator of prostate cancer proliferation and tumor growth and represents a new therapeutic target
- (2012) J D Paccez et al. ONCOGENE
- Emerging molecular targets in melanoma invasion and metastasis
- (2012) Jose L. Orgaz et al. Pigment Cell & Melanoma Research
- Suppression of heat shock protein 27 induces long-term dormancy in human breast cancer
- (2012) O. Straume et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Metformin Accelerates the Growth of BRAF V600E -Driven Melanoma by Upregulating VEGF-A
- (2012) Matthew J. Martin et al. Cancer Discovery
- Thrombospondin-1 Triggers Cell Migration and Development of Advanced Prostate Tumors
- (2011) V. Firlej et al. CANCER RESEARCH
- In Vivo Identification of Tumor- Suppressive PTEN ceRNAs in an Oncogenic BRAF-Induced Mouse Model of Melanoma
- (2011) Florian A. Karreth et al. CELL
- ERK1/2 and p38α/β Signaling in Tumor Cell Quiescence: Opportunities to Control Dormant Residual Disease
- (2011) Maria Soledad Sosa et al. CLINICAL CANCER RESEARCH
- The Two Faces of Interferon- in Cancer
- (2011) M. R. Zaidi et al. CLINICAL CANCER RESEARCH
- Human prostate cancer metastases target the hematopoietic stem cell niche to establish footholds in mouse bone marrow
- (2011) Yusuke Shiozawa et al. JOURNAL OF CLINICAL INVESTIGATION
- BEAM: A Randomized Phase II Study Evaluating the Activity of Bevacizumab in Combination With Carboplatin Plus Paclitaxel in Patients With Previously Untreated Advanced Melanoma
- (2011) Kevin B. Kim et al. JOURNAL OF CLINICAL ONCOLOGY
- Bone morphogenetic protein 7 in dormancy and metastasis of prostate cancer stem-like cells in bone
- (2011) Aya Kobayashi et al. JOURNAL OF EXPERIMENTAL MEDICINE
- Interferon-γ links ultraviolet radiation to melanomagenesis in mice
- (2011) M. Raza Zaidi et al. NATURE
- Molecular mechanisms and clinical applications of angiogenesis
- (2011) Peter Carmeliet et al. NATURE
- Hypoxia and MITF control metastatic behaviour in mouse and human melanoma cells
- (2011) Y Cheli et al. ONCOGENE
- Mitf is the key molecular switch between mouse or human melanoma initiating cells and their differentiated progeny
- (2011) Y Cheli et al. ONCOGENE
- GLI2 and M-MITF transcription factors control exclusive gene expression programs and inversely regulate invasion in human melanoma cells
- (2011) Delphine Javelaud et al. Pigment Cell & Melanoma Research
- The role of mitogen- and stress-activated protein kinase pathways in melanoma
- (2011) Pablo Lopez-Bergami Pigment Cell & Melanoma Research
- TGF- -RI Kinase Inhibitor SD-208 Reduces the Development and Progression of Melanoma Bone Metastases
- (2010) K. S. Mohammad et al. CANCER RESEARCH
- Metastatic Growth from Dormant Cells Induced by a Col-I-Enriched Fibrotic Environment
- (2010) D. Barkan et al. CANCER RESEARCH
- Matrix stiffness modulates proliferation, chemotherapeutic response, and dormancy in hepatocellular carcinoma cells
- (2010) Jörg Schrader et al. HEPATOLOGY
- Tumor cells disseminate early, but immunosurveillance limits metastatic outgrowth, in a mouse model of melanoma
- (2010) Jo Eyles et al. JOURNAL OF CLINICAL INVESTIGATION
- Discovery of a Novel Unfolded Protein Response Phenotype of Cancer Stem/Progenitor Cells from the Bone Marrow of Breast Cancer Patients
- (2010) Kai Bartkowiak et al. JOURNAL OF PROTEOME RESEARCH
- Late recurrence (10 years or more) of malignant melanoma in south-east Germany (Saxony) A single-centre analysis of 1881 patients with a follow-up of 10 years or more
- (2010) G Hansel et al. JOURNAL OF THE EUROPEAN ACADEMY OF DERMATOLOGY AND VENEREOLOGY
- Transmission of donor melanoma by organ transplantation
- (2010) Dirk C Strauss et al. LANCET ONCOLOGY
- COSMIC: mining complete cancer genomes in the Catalogue of Somatic Mutations in Cancer
- (2010) S. A. Forbes et al. NUCLEIC ACIDS RESEARCH
- Cancer stem cells versus phenotype-switching in melanoma
- (2010) Keith S. Hoek et al. Pigment Cell & Melanoma Research
- Integrins and Extracellular Matrix in Mechanotransduction
- (2010) M. A. Schwartz Cold Spring Harbor Perspectives in Biology
- Decoding Melanoma Metastasis
- (2010) William E. Damsky et al. Cancers
- Mechanisms of breast cancer bone metastasis
- (2009) Yunfei Zhang et al. CANCER LETTERS
- Transcriptional Switch of Dormant Tumors to Fast-Growing Angiogenic Phenotype
- (2009) N. Almog et al. CANCER RESEARCH
- Intravital Imaging Reveals Transient Changes in Pigment Production and Brn2 Expression during Metastatic Melanoma Dissemination
- (2009) S. Pinner et al. CANCER RESEARCH
- GAS6/Mer axis regulates the homing and survival of the E2A/PBX1-positive B-cell precursor acute lymphoblastic leukemia in the bone marrow niche
- (2009) Yusuke Shiozawa et al. EXPERIMENTAL HEMATOLOGY
- Oncogenic B-RAF Negatively Regulates the Tumor Suppressor LKB1 to Promote Melanoma Cell Proliferation
- (2009) Bin Zheng et al. MOLECULAR CELL
- BrafV600E cooperates with Pten loss to induce metastatic melanoma
- (2009) David Dankort et al. NATURE GENETICS
- Real-time imaging reveals the single steps of brain metastasis formation
- (2009) Yvonne Kienast et al. NATURE MEDICINE
- Dormancy of metastatic melanoma
- (2009) Liliana Ossowski et al. Pigment Cell & Melanoma Research
- Integrin 1-focal adhesion kinase signaling directs the proliferation of metastatic cancer cells disseminated in the lungs
- (2009) T. Shibue et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- TNFR1 Signaling and IFN-γ Signaling Determine whether T Cells Induce Tumor Dormancy or Promote Multistage Carcinogenesis
- (2008) Nele Müller-Hermelink et al. CANCER CELL
- In vivo Switching of Human Melanoma Cells between Proliferative and Invasive States
- (2008) K. S. Hoek et al. CANCER RESEARCH
- Inhibition of Metastatic Outgrowth from Single Dormant Tumor Cells by Targeting the Cytoskeleton
- (2008) D. Barkan et al. CANCER RESEARCH
- Annexin II/Annexin II receptor axis regulates adhesion, migration, homing, and growth of prostate cancer
- (2008) Yusuke Shiozawa et al. JOURNAL OF CELLULAR BIOCHEMISTRY
- Positive crosstalk between ERK and p38 in melanoma stimulates migration and in vivo proliferation
- (2008) Yeriel Estrada et al. Pigment Cell & Melanoma Research
Add your recorded webinar
Do you already have a recorded webinar? Grow your audience and get more views by easily listing your recording on Peeref.
Upload NowBecome a Peeref-certified reviewer
The Peeref Institute provides free reviewer training that teaches the core competencies of the academic peer review process.
Get Started